(Q37352049)

19 August 2017

Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort (English)

1 reference

19 August 2017

1 reference

13

Vered Stearns

1 reference

19 August 2017

12

David A Flockhart

1 reference

19 August 2017

Anna Maria V. Storniolo

10

object named as

Anna Maria Storniolo

1 reference

19 August 2017

4

Faouzi Azzouz

1 reference

19 August 2017

9

Anne T Nguyen

1 reference

19 August 2017

5

Todd C Skaar

1 reference

19 August 2017

8

Santosh Philips

1 reference

19 August 2017

6

Zereunesay Desta

1 reference

19 August 2017

2

James M Rae

1 reference

19 August 2017

N Lynn Henry

1

1 reference

19 August 2017

Lang Li

3

1 reference

19 August 2017

Matthew J Sikora

7

1 reference

19 August 2017

Daniel F Hayes

11

1 reference

19 August 2017

Consortium on Breast Cancer Pharmacogenomics Investigators

14

1 reference

19 August 2017

language of work or name

English

0 references

publication date

20 January 2009

1 reference

Breast Cancer Research and Treatment

19 August 2017

1 reference

19 August 2017

117

1 reference

19 August 2017

3

1 reference

19 August 2017

571-575

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-009-0309-1

19 August 2017

0 references

cites work

Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746261

The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746261

Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746261

Tamoxifen, hot flashes and recurrence in breast cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746261

Ontogeny of dextromethorphan O- and N-demethylation in the first year of life

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746261

Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746261

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746261

Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746261

Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746261

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746261

Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746261

The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746261

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746261

Methodologic lessons learned from hot flash studies

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746261

Tamoxifen in the treatment of breast cancer

2 September 2018

1 reference

12 December 2020

Definitions of hot flashes in breast cancer survivors

1 reference

12 December 2020

Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment

1 reference

12 December 2020

Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer

1 reference

12 December 2020

Tamoxifen-induced hot flashes

1 reference

12 December 2020

10.1007/S10549-009-0309-1

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19153830

1 reference